SEC Form SC 13G/A filed by Embecta Corp. (Amendment)

2/14/24 10:04:43 AM ET

Medical/Dental Instruments

Health Care

Get the next $EMBC alert in real time by email

SC 13G/A 1 embc13gadec23.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) EMBECTA CORP (Name of Issuer) COMMON STOCK (Title of Class of Securities) 29082K105 (CUSIP NUMBER) December 31, 2023 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is filed: [x] Rule 13d - 1(b) Rule 13d - 1(c) Rule 13d - 1(d) 1. Name of Reporting Person T. Rowe Price Investment Management, Inc. 85-4328500 2. Check the Appropriate Box if a Member of a Group NOT APPLICABLE 3. SEC Use Only 4. Citizenship or Place of Organization Maryland Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power* 0 6. Shared Voting Power* 0 7. Sole Dispositive Power* 0 8. Shared Dispositive Power 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 0 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares NOT APPLICABLE 11. Percent of Class Represented by Amount in Row 9 0.0% 12. Type of Reporting Person IA *Any shares reported in Items 5 and 6 are also reported in Item 7. Item 1(a) Name of Issuer: EMBECTA CORP Item 1(b) Address of Issuer's Principal Executive Offices: 1209 ORANGE STREET, WILMINGTON, DELAWARE 19801 Item 2(a) Name of Person(s) Filing: (1) T. Rowe Price Investment Management, Inc. (Price Investment Management) Item 2(b) Address of Principal Business Office: 101 E. Pratt Street, Baltimore, MD 21201 Item 2(c) Citizenship or Place of Organization: (1) Maryland Item 2(d) Title of Class of Securities: COMMON STOCK Item 2(e) Cusip Number: 29082K105 Item 3: The person filing this Schedule 13G is an: X Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 Item 4: Reference is made to Items 5-11 on the preceding pages of this Schedule 13G. Item 5: Ownership of Five Percent or Less of a Class This statement is being filed to report the fact that, as of the date of this report, the reporting person(s) has (have) ceased to be the beneficial owner of more than five percent of the class of securities. Item 6: Ownership of More than Five Percent on Behalf of Another Person (1) Price Investment Management does not serve as custodian of the assets of any of its clients; accordingly, in each instance only the client or the client's custodian or trustee bank has the right to receive dividends paid with respect to, and proceeds from the sale of, such securities. The ultimate power to direct the receipt of dividends paid with respect to, and the proceeds from the sale of, such securities, is vested in the individual and institutional clients which Price Investment Management serves as investment adviser. Any and all discretionary authority which has been delegated to Price Investment Management may be revoked in whole or in part at any time. Except as may be indicated if this is a joint filing with one of the registered investment companies sponsored by Price Investment Management which it also serves as investment adviser ("T. Rowe Price Funds"), not more than 5% of the class of such securities is owned by any one client subject to the investment advice of Price Investment Management. Item 7: Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not Applicable Item 8: Identification and Classification of Members of the Group Not Applicable Item 9: Notice of Dissolution of Group Not Applicable Item 10: Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. T. Rowe Price Investment Management, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Investment Management is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. T. Rowe Price Investment Management, Inc. Date: February 14, 2024 Signature: /s/ Armando Capasso Name & Title: Armando Capasso, Vice President 12/31/2023

Get the next $EMBC alert in real time by email

Recent Analyst Ratings for

$EMBC

Date	Price Target	Rating	Analyst
4/10/2025	$15.00	Neutral	Mizuho
12/2/2024	$13.00 → $20.00	Underweight → Equal-Weight	Morgan Stanley
11/27/2024	$26.00	Neutral → Buy	BTIG Research
10/20/2023		Peer Perform	Wolfe Research
1/6/2023	$28.00	Equal-Weight → Underweight	Morgan Stanley
9/8/2022		Neutral	BTIG Research
8/1/2022	$33.00	Equal-Weight	Morgan Stanley
6/21/2022	$25.00	Underperform	BofA Securities

More analyst ratings

SEC Form SC 13G/A filed by Embecta Corp. (Amendment)

Chat with this insight

Recent Analyst Ratings for $EMBC

$EMBC Press Releases

Fastest customizable press release news feed in the world

embecta to Participate in Investor Events

embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day

Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results

$EMBC Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Director Melcher David F bought $105,995 worth of shares (10,000 units at $10.60), increasing direct ownership by 13% to 86,681 units (SEC Form 4)

Director Melcher David F bought $177,646 worth of shares (13,000 units at $13.67), increasing direct ownership by 20% to 76,681 units (SEC Form 4)

Melcher David F bought $32,500 worth of shares (2,000 units at $16.25), increasing direct ownership by 5% to 45,080 units (SEC Form 4)

$EMBC Financials

Live finance-specific insights

Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results

embecta Announces Quarterly Cash Dividend

embecta to Report Fiscal Second Quarter 2025 Financial Results

$EMBC Leadership Updates

Live Leadership Updates

PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair

Zimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors

$EMBC Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Melcher David F bought $105,995 worth of shares (10,000 units at $10.60), increasing direct ownership by 13% to 86,681 units (SEC Form 4)

SVP and CFO Elguicze Jacob covered exercise/tax liability with 4,948 shares, decreasing direct ownership by 3% to 168,599 units (SEC Form 4)

SVP, Global Manuf./Sup. Chain Curtis Shaun covered exercise/tax liability with 3,249 shares, decreasing direct ownership by 5% to 59,061 units (SEC Form 4)

$EMBC Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by Embecta Corp.

Amendment: SEC Form SC 13G/A filed by Embecta Corp.

SEC Form SC 13G filed by Embecta Corp.

$EMBC SEC Filings

SEC Form SD filed by Embecta Corp.

Embecta Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

Amendment: SEC Form SCHEDULE 13G/A filed by Embecta Corp.

$EMBC Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Mizuho initiated coverage on Embecta Corp. with a new price target

Embecta Corp. upgraded by Morgan Stanley with a new price target

Embecta Corp. upgraded by BTIG Research with a new price target

Recent Analyst Ratings for
$EMBC

$EMBC
Press Releases

$EMBC
Insider Purchases

$EMBC
Financials

$EMBC
Leadership Updates

$EMBC
Insider Trading

$EMBC
Large Ownership Changes

$EMBC
SEC Filings

$EMBC
Analyst Ratings